![Kevin Heller](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profiel
Kevin N.
Heller worked as Senior Medical Director at AstraZeneca PLC from 2013 to 2015.
He served as VP & Head-Antibody Clinical Development at Incyte Corp.
from 2015 to 2018.
He was Chief Medical Officer at NextCure, Inc. from 2018 to 2020.
He held the position of Executive Vice President-Research & Development at Jasper Therapeutics, Inc. from 2021 to 2022.
Dr. Heller earned a doctorate from George Washington University and completed undergraduate studies at Yale University.
Eerdere bekende functies van Kevin Heller
| Bedrijven | Functie | Einde |
|---|---|---|
| JASPER THERAPEUTICS, INC. | Hoofd Techniek/Wetenschap/O&O | 17-03-2022 |
| NEXTCURE, INC. | Hoofd Techniek/Wetenschap/O&O | 04-08-2020 |
| INCYTE CORPORATION | Corporate Officer/Principal | 01-04-2018 |
| ASTRAZENECA PLC | Hoofd Techniek/Wetenschap/O&O | 01-05-2015 |
Opleiding van Kevin Heller
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
74
Eerstegraads connecties
6
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 6 |
|---|---|
Incyte Corp.
 Incyte Corp. Pharmaceuticals: MajorHealth Technology Engages in discovery, development and commercialization of proprietary therapeutics | Health Technology |
AstraZeneca PLC
 AstraZeneca PLC Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
George Washington University
 George Washington University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Yale University
 Yale University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
NextCure, Inc.
 NextCure, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which discovers and develops novel immuno medicines to treat cancer & immune related diseases | Health Technology |
Jasper Therapeutics, Inc.
 Jasper Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company which engages in enabling cures through hematopoietic stem cell therapy | Health Technology |
